See more : Biogen Inc. (0R1B.L) Income Statement Analysis – Financial Results
Complete financial analysis of Regional Health Properties, Inc. (RHE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Regional Health Properties, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- 8000 Inc (EIGH) Income Statement Analysis – Financial Results
- Global Health Limited (MEDANTA.NS) Income Statement Analysis – Financial Results
- C.S. Lumber Co., Inc (7808.T) Income Statement Analysis – Financial Results
- Eagle Point Credit Company Inc. (ECCB) Income Statement Analysis – Financial Results
- Adbri Limited (ABC.AX) Income Statement Analysis – Financial Results
Regional Health Properties, Inc. (RHE)
About Regional Health Properties, Inc.
Regional Health Properties, Inc., through its subsidiaries, operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Its business principally consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities. The company's facilities provide a range of healthcare services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for long-term and short-stay patients and residents. As of December 31, 2021, it owned, leased, or managed 24 facilities primarily in the Southeastern United States of America. The company was incorporated in 1991 and is headquartered in Suwanee, Georgia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 17.16M | 35.93M | 26.69M | 17.58M | 20.13M | 22.05M | 25.15M | 27.34M | 18.40M | 193.31M | 222.85M | 213.96M | 151.35M | 53.24M | 26.69M | 24.79M | 23.67M | 22.55M | 21.90M | 18.29M | 16.45M |
Cost of Revenue | 12.98M | 25.95M | 16.38M | 7.23M | 7.31M | 9.32M | 8.68M | 8.69M | 5.76M | 166.51M | 192.64M | 187.05M | 122.22M | 32.39M | 15.37M | 15.65M | 14.76M | 14.28M | 13.60M | 11.25M | 0.00 |
Gross Profit | 4.18M | 9.98M | 10.31M | 10.35M | 12.83M | 12.73M | 16.47M | 18.64M | 12.64M | 26.80M | 30.21M | 26.92M | 29.13M | 20.85M | 11.32M | 9.14M | 8.91M | 8.27M | 8.30M | 7.04M | 16.45M |
Gross Profit Ratio | 24.38% | 27.77% | 38.63% | 58.85% | 63.71% | 57.72% | 65.47% | 68.20% | 68.71% | 13.86% | 13.56% | 12.58% | 19.25% | 39.16% | 42.41% | 36.88% | 37.63% | 36.68% | 37.89% | 38.48% | 100.00% |
Research & Development | 0.00 | -0.26 | -0.04 | -0.03 | 0.24 | -0.54 | 0.02 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 3.98M | 4.65M | 3.90M | 3.37M | 3.19M | 3.69M | 4.49M | 7.71M | 10.54M | 18.18M | 21.57M | 16.83M | 22.53M | 0.00 | 0.00 | 0.00 | 7.75M | 7.11M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.98M | 4.65M | 3.90M | 3.37M | 3.19M | 3.69M | 4.49M | 7.71M | 10.54M | 18.18M | 21.57M | 16.83M | 22.53M | 0.00 | 0.00 | 0.00 | 7.75M | 7.11M | 6.73M | 5.52M | 0.00 |
Other Expenses | 1.01M | 4.38M | 3.83M | 4.68M | 4.17M | -52.00K | -474.00K | -72.00K | -918.00K | -888.00K | -306.00K | 520.00K | 3.94M | 22.50M | 9.55M | 9.13M | 847.44K | 748.31K | 806.00K | 698.48K | 0.00 |
Operating Expenses | 4.99M | 9.03M | 7.73M | 8.05M | 7.37M | 13.52M | 11.33M | 14.39M | 20.28M | 25.48M | 29.51M | 23.68M | 26.46M | 22.50M | 9.55M | 9.13M | 8.59M | 7.86M | 7.53M | 6.22M | 0.00 |
Cost & Expenses | 17.97M | 34.98M | 24.11M | 15.29M | 14.67M | 22.84M | 20.01M | 23.08M | 26.04M | 191.99M | 222.15M | 210.73M | 148.68M | 54.89M | 24.92M | 24.78M | 23.36M | 22.14M | 21.13M | 17.47M | 0.00 |
Interest Income | 0.00 | 2.53M | 2.67M | 2.78M | 5.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.74K | 5.47K | 23.29K | 59.30K | 26.57K | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.75M | 2.53M | 2.67M | 2.78M | 5.27M | 5.93M | 4.10M | 6.89M | 8.46M | 10.78M | 12.89M | 14.20M | 7.38M | 2.37M | 1.21M | 1.30M | 1.05M | 2.49M | 1.60M | 840.29K | 0.00 |
Depreciation & Amortization | 2.26M | 39.89M | 24.16M | 15.29M | 19.94M | 28.77M | 20.01M | 23.08M | 7.35M | 7.30M | 7.94M | 6.85M | 3.94M | 1.28M | 918.85K | 882.90K | 847.44K | 748.31K | 806.00K | 698.48K | 0.00 |
EBITDA | 1.45M | 6.29M | 3.98M | 5.19M | 3.64M | -1.44K | 10.01M | 9.82M | -29.95K | 7.74M | 1.14M | 10.60M | 3.94M | -613.34K | 918.85K | 882.90K | 1.16M | 1.16M | 1.57M | 1.52M | 16.45M |
EBITDA Ratio | 8.45% | 17.50% | 14.90% | 28.82% | 44.17% | 17.19% | 37.90% | 34.67% | -6.60% | 4.00% | 3.74% | 4.96% | 4.23% | -0.67% | 10.11% | 5.14% | 5.05% | 7.07% | 7.16% | 8.34% | 100.00% |
Operating Income | -804.00K | 3.88M | 1.39M | 2.29M | 5.46M | -792.00K | 5.14M | 4.26M | -7.64M | 1.32M | 695.00K | 3.23M | 2.67M | -1.65M | 1.77M | 12.38K | 311.72K | 407.65K | 766.23K | 818.95K | 16.45M |
Operating Income Ratio | -4.68% | 10.81% | 5.19% | 13.05% | 27.13% | -3.59% | 20.43% | 15.56% | -41.53% | 0.68% | 0.31% | 1.51% | 1.76% | -3.10% | 6.65% | 0.05% | 1.32% | 1.81% | 3.50% | 4.48% | 100.00% |
Total Other Income/Expenses | -3.08M | -6.86M | -3.67M | -2.90M | -588.00K | -5.29M | -4.63M | 1.28M | -10.06M | 11.44M | -9.34M | -15.20M | -6.43M | -478.79K | -1.25M | -860.63K | -1.12M | -2.85M | 3.58K | 48.01K | -16.45M |
Income Before Tax | -3.89M | -6.87M | -1.14M | -604.00K | 4.87M | -12.01M | 506.00K | 5.80M | -17.70M | -12.76M | -10.97M | -14.20M | -5.33M | -2.16M | 522.91K | -906.17K | -805.97K | -2.44M | 769.81K | 811.31K | 0.00 |
Income Before Tax Ratio | -22.65% | -19.11% | -4.26% | -3.44% | 24.21% | -54.46% | 2.01% | 21.23% | -96.20% | -6.60% | -4.92% | -6.63% | -3.52% | -4.05% | 1.96% | -3.65% | -3.41% | -10.83% | 3.52% | 4.44% | 0.00% |
Income Tax Expense | 0.00 | 8.22M | 1.52M | 2.74M | 4.63M | -38.00K | -188.00K | -163.00K | 110.00K | 132.00K | 142.00K | -85.00K | 263.20K | 42.57K | 42.57K | 170.01K | -178.42K | 2.85M | 1.65M | 596.11K | -14.67K |
Net Income | -3.89M | -15.09M | -2.66M | -3.34M | 241.00K | -11.90M | -985.00K | -7.46M | -23.52M | -12.90M | -12.57M | -5.05M | -6.16M | -2.74M | 440.28K | -1.08M | -218.93K | -2.44M | -884.05K | 222.84K | 14.67K |
Net Income Ratio | -22.65% | -42.00% | -9.96% | -19.02% | 1.20% | -53.96% | -3.92% | -27.30% | -127.82% | -6.67% | -5.64% | -2.36% | -4.07% | -5.15% | 1.65% | -4.34% | -0.93% | -10.83% | -4.04% | 1.22% | 0.09% |
EPS | 21.05 | -8.50 | -1.53 | -1.98 | 0.14 | -7.10 | -0.60 | -4.50 | -14.34 | -8.63 | -10.07 | -4.32 | -7.05 | -4.34 | 1.20 | -2.95 | -0.60 | -11.32 | -4.81 | 0.41 | 0.10 |
EPS Diluted | 21.05 | -8.50 | -1.53 | -1.98 | 0.14 | -7.10 | -0.60 | -4.50 | -14.34 | -8.63 | -10.02 | -4.31 | -7.05 | -4.34 | 0.98 | -2.95 | -0.60 | -11.32 | -4.81 | 0.41 | 0.10 |
Weighted Avg Shares Out | 1.88M | 1.78M | 1.73M | 1.69M | 1.69M | 1.68M | 1.65M | 1.66M | 1.64M | 1.49M | 1.25M | 1.17M | 874.25K | 632.07K | 377.89K | 365.24K | 365.24K | 215.57K | 183.71K | 159.28K | 141.49K |
Weighted Avg Shares Out (Dil) | 1.88M | 1.78M | 1.73M | 1.69M | 1.69M | 1.68M | 1.65M | 1.66M | 1.64M | 1.49M | 1.25M | 1.17M | 874.25K | 632.07K | 426.93K | 365.24K | 365.24K | 215.57K | 183.71K | 159.28K | 141.49K |
Regional Health Properties Reports Third Quarter 2024 Financial Results
Regional Health Properties, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal
NYSE American to Commence Delisting Proceedings Against Regional Health Properties, Inc. (RHE)
Yield Investing Expands Global Footprint with Asia Office Launch
Regional Health Properties Reports Fourth Quarter and Full Year 2023 Financial Results
Regional Health Properties Reports Third Quarter 2023 Financial Results
Regional Health Properties Reports Second Quarter 2023 Financial Results
Regional Health Properties, Inc. Announces Receipt of Acceptance Letter from NYSE American
Regional Health Properties, Inc. Announces Commencement of Trading of Series B Preferred Stock on OTC Markets
Regional Health Properties, Inc. Announces Receipt of Notice of Noncompliance from NYSE American
Source: https://incomestatements.info
Category: Stock Reports